Arrowstreet Capital, Limited Partnership Teva Pharmaceutical Industries LTD Transaction History
Arrowstreet Capital, Limited Partnership
- $122 Billion
- Q4 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 6,990,407 shares of TEVA stock, worth $115 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
6,990,407
Previous 14,897,625
53.08%
Holding current value
$115 Million
Previous $268 Million
42.61%
% of portfolio
0.13%
Previous 0.22%
Shares
21 transactions
Others Institutions Holding TEVA
# of Institutions
678Shares Held
578MCall Options Held
25.5MPut Options Held
14.7M-
Black Rock Inc. New York, NY43MShares$708 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$641 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.7MShares$603 Million48.01% of portfolio
-
Menora Mivtachim Holdings Ltd.28.4MShares$467 Million3.94% of portfolio
-
Exor Capital LLP London, X027.2MShares$448 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.3B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...